AFYA's Medical Seats Increase to 220 at UNIMA Alagoas in Brazil

Company Developments - Afya Limited (AFYA) has received authorization to increase medical seats at Centro Universitário de Maceió (UNIMA Alagoas) to a total of 220, adding 80 new seats, which will require an additional payment of R$ 1.25 million per seat approved [1] - The increase in medical seats contributes to AFYA's total of 3,583 approved seats, enhancing its capacity to provide quality medical education in Brazil [1] Price Performance - AFYA's shares have increased by 5.6% over the past three months, outperforming the Zacks Schools industry's growth of 3.1% [2] - The Zacks Consensus Estimate for AFYA's 2024 earnings per share (EPS) has been revised upward to $1.63, reflecting a year-over-year growth of 27.3% [2] - The estimate for second-quarter EPS has also increased, indicating a growth of 27.6% compared to the same quarter last year [2] Analyst Ratings - AFYA holds a Zacks Rank of 2 (Buy), indicating positive analyst sentiment towards the stock [4] - The company has a VGM Score of A, supported by both Value and Growth Scores of A, reflecting strong analyst optimism about its potential [3]